Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,37 USD | +4,88 % | -8,21 % | +14,26 % |
Resumen de negocios
Número de empleados: 7
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Oren Gilad
CEO | Chief Executive Officer | 56 | 01/05/22 |
John Hamill
DFI | Director of Finance/CFO | 60 | 30/01/23 |
Zeev Weiss
PRN | Corporate Officer/Principal | 62 | 01/05/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01/01/15 |
John Henneman
BRD | Director/Board Member | 62 | 01/08/19 |
Rifat Pamukcu
BRD | Director/Board Member | 66 | 01/05/22 |
Jean Bizzari
BRD | Director/Board Member | 69 | 23/08/23 |
Oren Gilad
CEO | Chief Executive Officer | 56 | 01/05/22 |
Marc Duey
BRD | Director/Board Member | 68 | 01/05/22 |
Richard Peters
CHM | Chairman | 61 | 30/06/20 |
Director/Board Member | 70 | 01/05/22 | |
Gabriela Gruia
BRD | Director/Board Member | 67 | 05/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 56 227 | 0 | 0 | 83,50 % |
Acción B | 1 | 5 430 215 | 4 534 187 ( 83,50 %) | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+14,26 % | 29,16 M | |
+3,13 % | 43,43 mil M | |
+48,83 % | 41,69 mil M | |
+8,49 % | 41,31 mil M | |
-10,82 % | 27,14 mil M | |
+8,26 % | 25,28 mil M | |
-23,69 % | 18,47 mil M | |
+1,58 % | 12,33 mil M | |
+32,83 % | 12,59 mil M | |
+6,63 % | 11,03 mil M |
- Bolsa de valores
- Acciones
- Acción APRE
- Empresa Aprea Therapeutics, Inc.